Thymidylate kinase: an old topic brings new perspectives

Area of Science:

• Biochemistry
• Enzymology
• Drug Discovery

Background:

• Thymidylate kinase (TMPK) is essential for pyrimidine synthesis and cell proliferation.
• TMPK plays a vital role in activating nucleoside prodrugs, including anti-HIV agents.
• TMPK is increasingly recognized as a validated drug target for infectious diseases and cancer.

Purpose of the Study:

• To review current research on TMPKs in eukaryotes, prokaryotes, and viruses.
• To consolidate knowledge on TMPK enzyme kinetics and structures.
• To provide insights for designing novel TMPK inhibitors.

Main Methods:

• Literature review of existing studies on TMPKs.
• Analysis of TMPK enzyme kinetics and structural data.
• Exploration of TMPK's role in drug activation and therapeutic strategies.

Main Results:

• TMPK is a validated target for developing antibiotics against Staphylococcus aureus.
• Inhibiting human TMPK enhances doxorubicin's efficacy against colon cancer cells.
• TMPK's structure and function are conserved across diverse organisms.

Conclusions:

• TMPK is a promising drug target for antimicrobial and anticancer therapies.
• Further research into TMPK inhibitors could lead to new treatment options.
• Understanding TMPK across different species is key for rational drug design.